ADAM9 and infection: Antibody pretreatment inhibited infection of HAP1 cells with EMCV, but not with CV-B3 (Fig. 4B), indicating that the support of EMCV infection by endogenous ADAM9 takes place at the cell surface or in the endocytic compartment.